AAAAAA
Results:
1-8
|
Results: 8
Authors:
SCHMIDT EK
ANTONIN KH
FLESCH G
RACINEPOON A
Citation: Ek. Schmidt et al., AN INTERACTION STUDY WITH CIMETIDINE AND THE NEW ANGIOTENSIN-II ANTAGONIST VALSARTAN, European Journal of Clinical Pharmacology, 53(6), 1998, pp. 451-458
Authors:
ANTONIN KH
RAK R
BIECK PR
PREISS R
SCHENKER U
HASTEWELL J
FOX R
MACKAY M
Citation: Kh. Antonin et al., THE ABSORPTION OF HUMAN CALCITONIN FROM THE TRANSVERSE COLON OF MAN, International journal of pharmaceutics, 130(1), 1996, pp. 33-39
Authors:
ZEEH J
FUCHS L
BERGMANN W
ANTONIN KH
DEGEL F
BIECK P
PLATT D
Citation: J. Zeeh et al., INFLUENCE OF AGE, FRAILTY AND LIVER-FUNCTION ON THE PHARMACOKINETICS OF BROFAROMINE, European Journal of Clinical Pharmacology, 49(5), 1996, pp. 387-391
Authors:
HASTEWELL J
ANTONIN KH
FOX R
MACKAY M
Citation: J. Hastewell et al., THE COLONIC ABSORPTION OF HUMAN CALCITONIN - THE EFFECTS OF INCREASING LOCAL CONCENTRATION AND COADMINISTRATION WITH A PROTEASE INHIBITOR, International journal of pharmaceutics, 126(1-2), 1995, pp. 245-251
Authors:
GLEITER CH
MUHLBAUER B
SCHULZ RM
NILSSON E
ANTONIN KH
BIECK PR
Citation: Ch. Gleiter et al., MONOAMINE-OXIDASE INHIBITION BY THE MAO-A INHIBITORS BROFAROMINE AND CLORGYLINE IN HEALTHY-VOLUNTEERS, Journal of neural transmission, 95(3), 1994, pp. 241-245
Authors:
BIECK PR
ANTONIN KH
FARGER G
NILSSON EB
SCHMIDT EK
DOSTERT P
BENEDETTI MS
WALDMEIER PC
Citation: Pr. Bieck et al., CLINICAL-PHARMACOLOGY OF THE NEW COMT INHIBITOR CGP-28014, Neurochemical research, 18(11), 1993, pp. 1163-1167
Authors:
BIECK PR
ANTONIN KH
SCHMIDT E
Citation: Pr. Bieck et al., CLINICAL-PHARMACOLOGY OF REVERSIBLE MONOAMINE OXIDASE-A INHIBITORS, Clinical neuropharmacology, 16, 1993, pp. 190000034-190000041
Authors:
FEIFEL N
KUCHER K
FUCHS L
JEDRYCHOWSKI M
SCHMIDT E
ANTONIN KH
BIECK PR
GLEITER CH
Citation: N. Feifel et al., ROLE OF CYTOCHROME-P4502D6 IN THE METABOLISM OF BROFAROMINE - A NEW SELECTIVE MAO-A INHIBITOR, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 265-269
Risultati:
1-8
|